# Fitpet

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fitpet

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.fitpet.co.kr
- Total disclosed funding: $25M
- Latest round: Series B (Jun 9, 2021)
- Investors on record: 10

## About

Founded in 2017 and based in Seoul, South Korea, Fitpet Inc. develops and supplies a urine examination kit for pets. It also operates a mobile app, known as Fitpet Ahead, which lets pet owners scan and acquire the result of urine examinations instantly. In June 2023, Fitpet Inc. raised KRW 23 billion in venture funding from new investor Korea Development Bank, with participation from returning investors LB Investment and BlueRun Ventures.

## Funding rounds

- Series B, Jun 9, 2021, $6.3M — Mirae Asset Venture Investment, Mirae Asset Capital
- Series B, Oct 7, 2020, $14M — LB Investment, Samsung Venture Investment, Mirae Asset Capital, Mirae Asset Venture Investment, Premier Partners, LSK Investment, PNP Investment
- Series A, Jun 28, 2019, $4.5M — LB Investment, Samsung Venture Investment, Mirae Asset Capital, Spring Camp
- Seed, Oct 1, 2018 — Spring Camp, Korea Tech Incubator for Startup
- Seed, Aug 17, 2018, $0.3M — Banks Foundation for Young Entrepreneurs, Spring Camp

## Investors

- Banks Foundation for Young Entrepreneurs — Seed
- Spring Camp (https://capitalatlas.ai/funds/spring-camp) — Seed, Series A
- Korea Tech Incubator for Startup — Seed
- LB Investment (https://capitalatlas.ai/funds/lb-investment) — Series A, Series B
- Samsung Venture Investment (https://capitalatlas.ai/funds/samsung-venture-investment) — Series A, Series B
- Mirae Asset Capital (https://capitalatlas.ai/funds/mirae-asset-capital) — Series A, Series B
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series B
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series B
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series B
- PNP Investment (https://capitalatlas.ai/funds/pnp-investment) — Series B